Literature DB >> 20024769

HIV and tuberculosis in Durban, South Africa: adherence to two medication regimens.

Inge B Corless1, Dean Wantland, Busi Bhengu, Patricia McInerney, Busi Ncama, Patrice K Nicholas, Chris McGibbon, Emily Wong, Sheila M Davis.   

Abstract

Given that antiretroviral (ARV) medication adherence has been shown to be high in resource-limited countries, the question remains as to whether adherence will remain at that level as medications become more widely available. Comparing adherence to tuberculosis (TB) medications, which have been readily available, and ARV medications may help to indicate the likely future adherence to ARVs as access to these medications becomes more widespread. This study examined sense of coherence, social support, symptom status, quality of life, and adherence to medications in two samples of individuals being treated either for TB or human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) at clinics in Durban, South Africa. Findings revealed the distinctive socio-economic backgrounds of the two cohorts. Although there were significant differences with regard to the psychosocial variables, there were no significant differences by the two samples in adherence to medications as well as adherence to appointments. Given the self-selected nature of the participants in this study, namely those able to attend clinic, as well as those likely to be adherent to ARVs, there is every reason for caution in the interpretations of these findings. As access to ARV medications becomes more widely available in South Africa, the question remains as to whether such high adherence will be maintained given the constraints of access to food and other basic necessities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20024769     DOI: 10.1080/09540120902729932

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  6 in total

Review 1.  Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies.

Authors:  Till Bärnighausen; Krisda Chaiyachati; Natsayi Chimbindi; Ashleigh Peoples; Jessica Haberer; Marie-Louise Newell
Journal:  Lancet Infect Dis       Date:  2011-10-24       Impact factor: 25.071

2.  Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.

Authors:  Amrita Daftary; Nesri Padayatchi; Max O'Donnell
Journal:  Glob Public Health       Date:  2014-07-18

3.  Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study.

Authors:  Pamela Naidoo; Karl Peltzer; Julia Louw; Gladys Matseke; Gugu McHunu; Bomkazi Tutshana
Journal:  BMC Public Health       Date:  2013-04-26       Impact factor: 3.295

4.  How to Evaluate Health-Related Quality of Life and Its Association with Medication Adherence in Pulmonary Tuberculosis - Designing a Prospective Observational Study in South Africa.

Authors:  Tanja Kastien-Hilka; Bernd Rosenkranz; Bryan Bennett; Edina Sinanovic; Matthias Schwenkglenks
Journal:  Front Pharmacol       Date:  2016-05-31       Impact factor: 5.810

5.  Patients infected by tuberculosis and human immunodeficiency virus facing their disease, their reactions to disease diagnosis and its implication about their families and communities, in Burkina Faso: a mixed focus group and cross sectional study.

Authors:  Ziemlé Clément Méda; Télesphore Somé; Issiaka Sombié; Daouda Maré; Donald E Morisky; Yi-Ming Arthur Chen
Journal:  BMC Res Notes       Date:  2016-07-29

Review 6.  Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis- a systematic review of global literature with focus on South Africa.

Authors:  Tanja Kastien-Hilka; Ahmed Abulfathi; Bernd Rosenkranz; Bryan Bennett; Matthias Schwenkglenks; Edina Sinanovic
Journal:  Health Qual Life Outcomes       Date:  2016-03-11       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.